Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts

<p><span lang="EN-US" style= "font-size: 11.0pt; line-height: 115%; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;" xml:lang="EN-US"><!--StartFragment --></span></p> <p class="pf0"><span class="cf0">Hear about the promise of combination therapies and dual and triple agonists in helping people with obesity lose weight and improve overall health.</span></p> <p class="pf0"><span class="cf0">Credit available for this activity expires: 11/11/26<br /></span><span class="cf0">Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.staging.medscape.org/viewarticle/1003041">https://www.medscape.org/viewarticle/1003041?ecd=bdc_podcast_libsyn_mscpedu</a></span></p> <p> </p>